• Title/Summary/Keyword: Chinese Traditional Medicine

검색결과 1,152건 처리시간 0.026초

학질(瘧疾)의 증상(症狀)과 기전(機轉)에 대한 문헌적(文獻的) 고찰(考察) -청대(淸代)까지 중국의서(中國醫書)를 중심(中心)으로- (A study of symptoms and pathogenesis of hakgil(瘧疾) in the chinese traditional medical literature until chung(淸) dinasty)

  • 류정아;박찬국
    • 대한한의학원전학회지
    • /
    • 제12권1호
    • /
    • pp.168-195
    • /
    • 1999
  • The hakgil is the important disease in the oriental medicine historically. In the preseant time also this disease continually appear all over the world. So purpose of this study is that consider the symptoms and pathogenesis of hakgil(瘧疾) with the point of view of oriental medicine. And in this study, the results are summarized as the followings. 1. The symptos of hakgil(瘧疾). 1) Rigor and heat spasm : The main symptoms of hakgil is the severe and periodical rigor and heat spasm. Generally the rigor first appear and later the heat spasm appear. According to the first and last, severe and weak, the hakgil is classified to hanhak(寒瘧), onhak(溫瘧), danhak(癉瘧), binhak(牝瘧). 2) The regulation of the time of spasm : The spasm occour in the same time daily or one time in two days, three days or several days. And the spasm time is regulary in day or night. 3) The term between the spasm and next one become later or faster. It can be decided that the becoming worse and better in the disease with the signs. 4) The seasonal property Generally the hakgil appear in summer and early autumn. 5) The other kind of hakgil there are five-organ hakgil(五臟瘧), six-kyung hakgil(六經瘧), janghak(瘴瘧), kuihak(鬼瘧), six-gi hakgil(六氣瘧), damhak(痰瘧), sikhak(食瘧), and so on. 6) The pulse condition of the hakgil is chiefly hyun(弦). 2. The pathogenesis of the hakgil 1) The cause of the hakgil The causes of the hakgil first are the seo(暑) or heat(熱) that make the problem in the cycle of five phases(五行). In the consequence, il open the hole of skin so that the pathogenic factors easily invade the humanbody and at the same time the pathogenic factor in the inside easily come out, that make the spasm. In the second time the pathogenic factor of yin(陰) - wind(風), cold(寒), water(水) invade through the opened skin to combine with the factor in the inside. Such condition make the hakgil and the accessory spasm. 2)The pathogenesis of hakgil(瘧疾) (1) The rigor and heat spasm of hakgil(瘧疾) appear because in summer the human body don't accomplish a task of summer because of hot weather or heat, so in autumn the ki(氣) of human body separate into yin(陰) and yang(陽), and the skin of human body is weaken so the saki(邪氣: pathogenic factors) is easily come into the human body. At this time the circulation of ki(氣) is obstructed, so the jungki(精氣: vital substance) apply to straighten the circulation of ki(氣), if the jungki(精氣: vital substance) help the yin(陰) the rigor spasm appear in the opposit direction the jungki(精氣: vital substance) help the yang(陽) the heat spasm appear. (2) The period of circulation of ki(氣) and jungki(精氣: vital substance) is one day, so the general period of spasm of hakgil(瘧疾) is one day, But if the saki(邪氣: pathogenic factors) come into the human body deeply, the jungki(精氣: vital substance) cannot apply 10 straighten the circulation of ki(氣) every day so the period of spasm become longer.

  • PDF

항해승제론(亢害承制論)에 대한 제가설(諸家說) 연구(硏究) (A study on all the theories about KangHaiChengZhiLun)

  • 윤창열
    • 대한한의학원전학회지
    • /
    • 제29권2호
    • /
    • pp.135-150
    • /
    • 2016
  • Objectives : KangHaiChengZhiLun (亢害承制論; If Excess Brings Harm, Lifing Qi (承氣) Restrains) was originally a theory that explained how the realms of nature remain in harmony and equilibrium. It later became an important theory for clinical trials of Traditional Chinese Medicine, explaining the physiological and pathological mechanism. Methods : The researcher considered all the annotations and the original text of SuWen(素問), LiuWeiZhiDaLun(六微旨大論) and theories of medical practitioners who applied KangHaiChengZhiLun(亢害承制論) to their clinical trials. Results & Conclusions : Wangbing (王氷) went with a theory that phenomena of Lifting Qi (承氣) take place in the realms of nature when Qi (氣) flourishes. In XinJiaoZheng(新校正), he wrote about two theories: one was that Six Kinds of Natural Factors (六氣) first work as the main Qi (本氣) but later bring about Lifting Qi. (終見下承之氣說); the other was that excessive Stagnation Qi (鬱氣) can be exploded and invite another accompanying Qi, Lifting Qi. (甚者兼其下承之氣說) Liuwansu (劉完素) had a theory that if Six Kinds of Natural Factors go disproportionately excessive, it becomes accompanied by imaginary Qi (假象) that conquers self. (反兼勝己之化說) $Wangl{\ddot{u}}$(王履) maintained that Lifting Qi usually works as a means to prevent Six Kinds of Natural Factors (六氣) from becoming rampant; but when Six Kinds of Natural Factors become overly excessive, Lifting Qi restrains them in order to maintain equilibrium. (防之與克勝說) Yutuan explained that since Excessive Qi (亢氣) does damage to the mother of Lifting Qi, Lifting Qi restrains Excessive Qi to protect Original Qi (元氣), its mother. (護救承者之元氣說) Gongtingxian was in favor of two theories: one argued that causes and symptoms of a disease differ from each other. (體用不同說); the other said that diseases are naturally cured if the patient finds out the time when Lifting Qi gains strength. (得承之時自愈說) Mashi (馬蒔) had a theory that Lifting Qi is generated when Six Kinds of Natural Factors are prosperous and reveals itself when its season comes. (極則生承氣 至本位著說) Zhangjiebin (張介賓) asserted that when Six Kinds of Natural Factors are thriving, Lifting Qi, as a restraining force, is generated to disperse the thriving natural factors and leads to a new one. (前之退而後之進說) Zhangqi (張琦)'s argument was that if Lifting Qi restrains the main Qi, a son of the main Qi is generated and every four season goes in harmony. (承氣制則生化說) Hemengyao (何夢瑤) had an argument that a son of the restrained Qi succeeds to its father and later achieves equilibrium by restraining Excessive Qi. (被克承父 制之平衡說).

왕느릅나무 껍질 열수 추출물의 마우스에서의 in vivo 면역조절 효과 (Immune-modulation Effect of Ulmus macrocarpa Hance Water Extract on Balb/c Mice)

  • 이인환;권다혜;이선희;이성도;김덕원;이종환;현숙경;김철민;김병우;강경화;황혜진;정경태
    • 생명과학회지
    • /
    • 제24권10호
    • /
    • pp.1151-1156
    • /
    • 2014
  • 약용식물은 염증, 감염증, 암과 같은 질병에 광범위하게 사용되고 있으며, 전통적으로 오래 동안 사용되어 왔다. 왕느릅나무(Ulmus macrocarpa Hance)는 느릅나무의 한 종으로서 중국, 일본을 비롯해 한국 전역에 분포하고 있으며, 줄기와 뿌리의 껍질을 유백피라 하여 한의학에서 피부염, 유방염, 부종 등에 사용하여 왔다. 이 연구의 목적은 유백피의 열수 추출물(Ulmus cortex water extract, UCWE)이 면역조절 기능을 가지고 있는지를 조사하는 것이다. UCWE 식이농도 30 mg/kg, 100 mg/kg, 300 mg/kg의 3개 군으로 나누어 14일 동안 식이한 후 면역반응을 측정하였다. IL-2, IL-12, IFN-${\gamma}$ 의 혈중 농도가 UCWE를 식이한 군에서 유의적으로 증가하였으며, lymphokine activated killer cells (LAK)을 이용한 세포매개 세포독성 시험에서도 정상군에 비해 UCWE를 식이한 군에서 유의적으로 증가하였다. 그러나, 간, 신장, 비장, 흉선의 무게변화는 UCWE를 식이한 군과 정상군과의 차이가 없었다. 이는 300 mg/kg 고농도의 2주간 식이가 장기에 영향을 거의 미치지 않는다는 것을 암시한다고 생각된다. 따라서, UCWE는 내부 장기에는 영향을 주지 않으며 면역기능을 향상시키는 효과를 가진다고 여겨진다.

소목(Caesalpinia sappan L.)의 에틸아세테이트 분획물이 Streptococcus mutans에 대한 항균활성 및 부착 억제 (Antimicrobial Activities and Adherence Inhibition on Streptococcus mutans by Ethyl Acetate Extract from Caesalpinia sappan L.)

  • 권현정;김용현;한국일;전미애;한만덕
    • 치위생과학회지
    • /
    • 제12권2호
    • /
    • pp.155-162
    • /
    • 2012
  • 본 연구는 소목(Caesalpinia sappan L.)의 6가지 유기용매 분획물 중 IP-3의 항균활성을 및 부착능을 측정하고 다음과 같은 결과를 얻었다. 1. Methanol에 의해 분리된 소목의 항균 물질 수율은 총 4.8%로 나타났으며, 여러 분획물 가운데 EtOAc 분획물(IP-3)에서 3.94%로 가장 높은 수율을 보였다. 2. 소목의 EtOAc 분획물에서 최종 정제된 활성물질은 UV 288.3 nm에서 최대 흡수피크를 나타내었으며, NMR spectrum을 통해 brazilin(($C_{16}H_{14}O_5$)으로 확인되었다. 3. S. mutans에 대한 소목의 EtOAc 분획물의 항균 활성은 최소억제농도(MIC) 3.1 mg/ml에서 균의 생장을 억제하였다. 4. S. mutans 부착억제효과는 하이드록시아파타이트(HA)를 S. mutans와 24 시간 동안 함께 배양한 대조군은 균 부착률이 높게 관찰되었으나, 소목의 EtOAc 분획물을 처리한 군에서는 HA에 S. mutans의 부착이 매우 적게 나타났다. 이상의 결과를 통해, 소목에서 추출된 EtOAc 분획에 존재하는 brazilin이 구강 내 우식원성세균에 강한 항균력을 가지고 있는 것으로 판단되며, 특히 S. mutans의 부착 억제능이 확인되어 우식원성 균주에 대한 생약치료제로 활용이 가능할 것으로 사료된다.

Effects of Astragalus membranaceus roots supplementation on growth performance, serum antioxidant and immune response in finishing lambs

  • Hao, Xiaoyan;Wang, Pengju;Ren, Youshe;Liu, Gentang;Zhang, Jianxin;Leury, Brian;Zhang, Chunxiang
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제33권6호
    • /
    • pp.965-972
    • /
    • 2020
  • Objective: Astragalus membranaceus root is a well-known traditional Chinese herbal medicine with many biological active constituents. This study was conducted to examine the effects of Astragalus membranaceus root powder (AMP) on growth performance, serum antioxidant and immune response in finishing lambs. Methods: A total of thirty-six Guangling fat-tailed ram lambs (body weight = 19±2 kg, mean±standard deviation) were randomly assigned to one of six treatments for a 40 d feeding period, with the first 10 d for adaptation. Treatments consisted of the lambs' basal diets with addition of 0, 5, 10, 15, 20, and 30 g/kg of diet of AMP. Results: Response to supplementation level of AMP was quadratic (p≤0.032) for final weight and ADG with the greatest at 10 g/kg of diet, but dry matter intake was not affected (p≥0.227) by treatments. The increase of AMP supplementation resulted in a quadratic response in contents of triglyceride and creatinine (p<0.05), with the lowest values for 10 and 20 g/kg of diet, respectively. A linear and quadratic decrease was observed in activity of alkaline phosphatase in serum of lambs. As the AMP supplementation increased, the activities of total superoxide dismutase and total antioxidant capacity increased linearly (p≤0.018) and hydroxyl radical (OH-) decreased linearly (p = 0.002). For catalase (CAT) and malondialdehyde (MDA), quadratic (p≤0.001) effects were observed among treatments, with the greatest CAT and lowest MDA values at 10 g/kg AMP. Additionally, supplementing AMP up to a level of 10 or 15 g/kg of diet quadratically increased immunoglobulin and interleukin contents in the serum. Conclusion: The results indicated that AMP can be used as natural feed additive in the ration of lambs to improve ADG, antioxidant status, and immune functions, and the optimal dose was 10 g/kg of diet under the condition of this experiment.

당귀(Angelica spp.)의 기원분석에 관한 분자생물학적 연구 현황 및 향후과제 (Current status on the development of molecular markers for differentiation of the origin of Angelica spp.)

  • 이신우;이수진;한은희;신의철;조계만;김윤희
    • Journal of Plant Biotechnology
    • /
    • 제44권1호
    • /
    • pp.12-18
    • /
    • 2017
  • 당귀는 우리나라를 포함하여 중국과 일본 등 아시아국가에서 유용하게 이용되는 한약재이다. 그러나 국가마다 그 기원을 달리하기 때문에 혼 오용이 심하고 국제시장에서 혼란을 불러일으킬 소지가 다분하다. 따라서 오래전부터 형태학적, 세포유전학적 분석과 지표성분을 이용한 화학적 판별 마커의 개발에 관한 연구가 많이 진행되어 왔다. 또한 최근에는 다양한 재배환경과 수확 후 가공 및 처리방법에도 비교적 안전한 유전자 단편의 염기서열 비교분석을 통한 분자생물학적 기술을 적용한 판별기술의 개발에 관한 연구결과 들이 발표되고 있다. 그러나 아직까지 이들 기술의 실용화를 통한 현장 적용에는 한계가 있으며 보다 많은 후속연구가 수행되어야 한다. 이에 본 논문에서는 현재까지의 연구결과를 바탕으로 얻어진 문제점을 논하고 향후 필요한 추가 연구 과제들에 관하여 기술하였다.

게르마늄 농도를 증가 시킨 동충하초 균사체 열수 추출액의 항암효과 (Anti-cancer Effect of Hot Water Extract from Mycelium in Germanium-enriched Cordyceps militaris)

  • 최정수;허지혜;김대진;남궁수민;이태복;이민우;김성욱
    • 대한임상검사과학회지
    • /
    • 제49권2호
    • /
    • pp.69-78
    • /
    • 2017
  • 게르마늄(Ge)은 거의 대부분의 영양분, 동물, 식물에서 발견되는 미량원소로 많은 연구를 통해 항균성 항바이러스성 항종양성 항돌연변이성 및 면역조절 효과를 지닌 것으로 알려져 있다. 또한, 동충하초는 중국의 전통적인 약용 버섯으로 항종양성, 항산화성 및 면역조절 효과 등 다양한 생물학적 활성을 지니고 있으며 미량원소를 축적시키기 효과적인 것으로 알려져 있다. 이런 특성을 이용하여 본 연구는 게르마늄 농도를 증가시킨 동충하초(CMGe)의 열수 추출액을 얻어내고 그 생물학적 특성을 실험하였다. 네 가지 암세포주 Ramos, A549, HepG2, CEM와 MSC에 대한 CMGe의 세포독성을 MTT assay를 통해 확인한 결과, CEM에서 항증식성이 가장 높고 MSC에 대한 세포독성은 낮은 것으로 확인되었다. 마지막으로 누드마우스에 인간 신경아교세포종(U87MG)을 이종이식하여 종양의 부피와 무게를 조사한 결과, CMGe열수 추출액 처리군에서 종양 부피와 무게의 감소를 확인할 수 있었다. 이런 결과는 CMGe가 앞으로 의약 및 제약산업에 다양하게 적용될 수 있을 것으로 기대된다.

솔장다리 추출물의 항비만 효과 (Anti-obesity Effect of Salsola collina Ethanol Extract)

  • 진경숙;이수현;권현주;김병우
    • 생명과학회지
    • /
    • 제27권8호
    • /
    • pp.888-895
    • /
    • 2017
  • 솔장다리(S. collina)는 건조한 대지에 널리 분포되어 있는 한해살이 식물로 한방에서는 고혈압의 치료에 사용되어왔으며 선행연구를 통해 솔장다리가 보유한 항산화 및 항암 활성을 밝힌바 있다. 본 연구에서는 솔장다리 에탄올 추출물(SCEE)의 항비만 활성을 췌장 lipase 효소 활성 억제능과 세포실험계를 이용하여 분석하였다. 그 결과 SCEE는 농도 의존적으로 lipase 효소 활성을 유의적으로 억제시켰으며, 3T3-L1 preadipocyte를 이용하여 지방세포 분화 및 지방생성, 생성된 지방의 분해에 미치는 영향을 분석한 결과 지방세포 분화, 세포 내 지방 축적, TG 함량 등을 독성 없이 농도의존적으로 억제하였고, 지방세포 내 중성지방을 유의적으로 분해시키는 것으로 나타났다. 이러한 솔장다리의 지방세포 분화 억제능은 핵심 작용 인자인 $C/EBP{\alpha}$, $C/EBP{\beta}$, 그리고 $PPAR{\gamma}$의 유전자 및 단백질 발현조절에서 기인함을 확인하였다. 이러한 결과는 솔장다리가 보유한 췌장 lipase 활성 저해능, 지방세포 분화 억제능, 지방세포 내 지방 분해능, 지방분화관련 인자 신호전달기전 조절을 통한 항비만 활성을 처음으로 밝혀낸 것이며 추후 계속적인 연구를 통해 활성 물질의 규명이 필요할 것으로 판단된다.

A Systematic Review of Risk Factors for Brain Metastases and Value of Prophylactic Cranial Irradiation in Non-Small Cell Lung Cancer

  • Sun, Dian-Shui;Hu, Li-Kuan;Cai, Ying;Li, Xiao-Mei;Ye, Lan;Hou, Hua-Ying;Wang, Cui-Hong;Jiang, Yu-Hua
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권3호
    • /
    • pp.1233-1239
    • /
    • 2014
  • Background: The incidence of brain metastases (BM) varies in patients with non-small cell lung cancer (NSCLC), calls into question the value of prophylactic cranial irradiation (PCI). It is possible that clinicopathologic characteristics are associated with the development of BM, but these have yet to be identified in detail. Thus, we conducted the present meta-analysis on risk factors for BM and the value of PCI in patients with NSCLC. Methods: Eligible data were extracted and the risk factors for BM and the value of PCI in patients with NSCLC were analyzed by calculating the pooled odds ratio (OR). Heterogeneity was detected using Q and I-squared statistics, and publication bias was tested by funnel plots and Egger's test. Results: Six randomized controlled trials with a focus on the value of PCI and 13 eligible studies with a focus on risk factors for BM were included. PCI significantly reduced the incidence of BM in patients with NSCLC (p=0.000, pooled OR=0.34, 95% confidence interval = 0.37-0.59). Compared with non-squamous cell carcinoma, squamous cell carcinoma was associated with a low incidence of BM in patients with NSCLC (p=0.000, pooled OR=0.47, 95% confidence interval =0.34-0.65). The funnel plot and Egger's test suggested that there was no publication bias in the current meta-analysis. Conclusions: This meta-analysis provides statistical evidence that compared with non-squamous cell carcinoma, squamous cell carcinoma can be used as a predictor for BM in patients with NSCLC, and PCI might reduce the incidence of BM in patients with NSCLC, but does not provide a survival benefit.

Phase II Trial of Loubo® (Lobaplatin) and Pemetrexed for Patients with Metastatic Breast Cancer not Responding to Anthracycline or Taxanes

  • Deng, Qian-Qian;Huang, Xin-En;Ye, Li-Hong;Lu, Yan-Yan;Liang, Yong;Xiang, Jin
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권1호
    • /
    • pp.413-417
    • /
    • 2013
  • Purpose: This phase II study was undertaken to determine the efficacy and safety of Loubo$^{(R)}$ (Lobaplatin) in combination with pemetrexed in treating patients with metastatic breast cancer who failed to respond to anthracycline or taxanes. Patients and Methods: Metastatic breast cancer cases who had previously received an anthracycline and a taxane in either adjuvant or metastatic settings, were enrolled. All patients were recruited from Jiangsu Cancer Hospital and Research Institute, and were treated with Loubo$^{(R)}$ (Lobaplatin) 35 $mg/m^2$ (intravenous; on day 1) and pemetrexed 500 $mg/m^2$ (intravenous; on day 1) every 21 days. Efficacy and side effects were evaluated after at least two cycles of chemotherapy. Results: All eligible 19 patients completed at least 2 cycles of chemotherapy with pemetrexed and lobaplatin, and were evaluable. Overall, 3 (15.8%) patients achieved partial response, 11 (57.9%) stable disease, 5 (26.3%) progression of disease, with no complete remission. Response rate was 15.8%, disease control rate was 42.1%. The median survival time was 10.3 months. Neutrophil suppression occurred in 36.8% of patients who had grade 2 toxicity, and 26.3% had grade 3, 26.4% had grade 4. Thrombocytopenia was encountered as follows: 21.1% grade 2, 15.8% grade 3 and 5.5% grade 4. Incidences of anemia were 10.5% in grade 2, 5.3% grade 3 and 0% grade 4. Only 5.3% of patients required packed red blood cell transfusion. Grade 3 digestive tract toxicity occurred in 5.5% of patients. Other toxicities included elevated transaminase,oral mucositis and skin rashes. Conclusions: The regimen of lobaplatin and pemetrexed is modestly active in metastatic breast cancer patients who failed anthracycline or taxanes, and the toxicity profile suggesting that the doses of chemotherapy should be further modified.